Is F-Star Therapeutics Inc (FSTX) a Good Buy in the Healthcare Sector?

Wednesday, February 08, 2023 02:43 PM | InvestorsObserver Analysts

Mentioned in this article

Is F-Star Therapeutics Inc (FSTX) a Good Buy in the Healthcare Sector?

F-Star Therapeutics Inc (FSTX) is around the top of the Healthcare sector according to InvestorsObserver. FSTX received an overall rating of 85, which means that it scores higher than 85% of stocks. Additionally, F-Star Therapeutics Inc scored a 70 in the Healthcare sector, ranking it higher than 70% of stocks in that sector.

FSTX has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on FSTX!

See Full FSTX Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With F-Star Therapeutics Inc Stock Today?

F-Star Therapeutics Inc (FSTX) stock has risen 5.33% while the S&P 500 is down -0.91% as of 2:40 PM on Wednesday, Feb 8. FSTX is higher by $0.24 from the previous closing price of $4.50 on volume of 633,059 shares. Over the past year the S&P 500 has fallen -8.74% while FSTX is higher by 31.30%. FSTX lost -$2.07 per share the over the last 12 months. Click Here to get the full Stock Report for F-Star Therapeutics Inc stock.